Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P1.11 - Screening and Early Detection (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 19
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.11-01 - The NELSON Triage Algorithm Applied to a Chinese Biopsied Population: A Pilot Study
16:45 - 18:00 | Presenter: Hubert Beaumont
- Abstract
Loading... -
+
P1.11-02 - Pathologic Comparison of Prevalent vs. Incident CT Lung Screen Detected Cancer in NCCN High-Risk Subjects: Are They Different?
16:45 - 18:00 | Presenter: Eric J Burks
- Abstract
Loading... -
+
P1.11-03 - MicroRNA with Ability to Reciprocal Regulation of Dicer and Drosha – Plasma Expression Status and Diagnostic Value in Non-Small Cell Lung Cancer
16:45 - 18:00 | Author(s): Anna Grenda
- Abstract
Loading... -
+
P1.11-04 - Size Measurement Variability of Solid Component of Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Kazutoshi Hamanaka
- Abstract
Loading... -
+
P1.11-05 - Metabolomic Profiling for Second Primary Lung Cancer Among Lung Cancer Survivors
16:45 - 18:00 | Presenter: Summer S Han
- Abstract
Loading... -
+
P1.11-06 - Lung Cancer Probability in New Perifissural Nodules Detected in a Lung Cancer Screening Study
16:45 - 18:00 | Presenter: Marjolein A Heuvelmans
- Abstract
Loading... -
+
P1.11-07 - Utility of the Maximum CT Value in Predicting Invasiveness of Pure GGNs
16:45 - 18:00 | Presenter: Junji Ichinose
- Abstract
Loading... -
+
P1.11-08 - AI Based Malignancy Prediction of Indeterminate Pulmonary Nodules: Robustness to CT Contrast Media
16:45 - 18:00 | Author(s): Quentin Chometon
- Abstract
Loading... -
+
P1.11-09 - The Delay of Lung Cancer Diagnosis Due to Misdiagnosing as Pulmonary Tuberculosis
16:45 - 18:00 | Presenter: Ana Rima
- Abstract
Loading... -
+
P1.11-10 - Optimizing Radiomics Features by Minimizing Boundary Effects and Normalizing with Opposite Lung Tissue Characteristics
16:45 - 18:00 | Presenter: Saeed Seyyedi
- Abstract
Loading... -
+
P1.11-11 - Comparing Lung Cancer Diagnosed by Low Dose CT (LDCT), Incidental Lung Nodule Program (ILNP), and Non-Program-Based Detection
16:45 - 18:00 | Presenter: Matthew P Smeltzer
- Abstract
Loading... -
+
P1.11-12 - Interrogation of an Exhaled MicroRNA Panel for Lung Cancer Risk Assessment
16:45 - 18:00 | Presenter: Simon D Spivack
- Abstract
Loading... -
+
P1.11-13 - Noninvasive Detection of Early Stage NSCLC EGFR Mutations Using Electric Field Induced Release and Measurement (EFIRM)
16:45 - 18:00 | Author(s): Fang Wei
- Abstract
Loading... -
+
P1.11-14 - Radiological Pleura-Tumor Proximity in Pure-Solid Clinical Stage I Lung Cancer: Its Influence on Lymph Node Metastasis and Recurrence
16:45 - 18:00 | Presenter: Toshiki Tanaka
- Abstract
Loading... -
+
P1.11-15 - Application of Lung-RADS vs. PAN-CAN Nodule Risk Calculation in the Alberta Lung Cancer Screening Study
16:45 - 18:00 | Presenter: Alain Tremblay
- Abstract
Loading... -
+
P1.11-17 - Discriminating Less Invasive Lesions of Early-Stage Lung Adenocarcinoma by Three-Dimensional Computed Tomography Analysis
16:45 - 18:00 | Presenter: Nobuyuki Yoshiyasu
- Abstract
Loading... -
+
P1.11-18 - A Classification-Based Machine Learning Method Reveals Exosomal miRNA Biomarkers for Patients with Pulmonary Ground Glass Nodule
16:45 - 18:00 | Presenter: Jia-Tao Zhang
- Abstract
Loading... -
+
P1.11-19 - Expression of TNFRII in Serum is Correlated with the Significant Risk of Subcentimeter Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yanwei Zhang
- Abstract
Loading... -
+
P1.11-19a - Gender Comparison in Lung Cancer Screening
16:45 - 18:00 | Presenter: Simran K Randhawa
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 23
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.12-01 - A Single-Arm Multi-Center Phase II Study of Apatinib in Patients with ES-SCLC After Second/Third-Line Chemotherapy
16:45 - 18:00 | Presenter: Yun Fan
- Abstract
Loading... -
+
P1.12-02 - Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Satoshi Igawa
- Abstract
Loading... -
+
P1.12-03 - A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
16:45 - 18:00 | Presenter: Yutao Liu
- Abstract
Loading... -
+
P1.12-04 - A Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Shun Lu
- Abstract
Loading... -
+
P1.12-05 - Efficacy of Perioperative Chemotherapy for High-Grade Neuroendocrine Tumors
16:45 - 18:00 | Presenter: Hiroyuki Ogawa
- Abstract
Loading... -
+
P1.12-06 - Pulmonary Neuroendocrine (Carcinoid) Tumors: CommNETs/NANETS Endorsement and Update of the ENETs Best Practice Consensus
16:45 - 18:00 | Presenter: Simron Singh
- Abstract
Loading... -
+
P1.12-06a - Rovalpituzumab Tesirine Maintenance Therapy Following 1st Line Platinum‑Based Chemotherapy in Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Philip Komarnitsky
- Abstract
Loading... -
+
P1.12-06b - Rovalpituzumab Tesirine vs Topotecan in Patients with Advanced Small Cell Lung Cancer Following 1st Line Chemotherapy
16:45 - 18:00 | Presenter: Philip Komarnitsky
- Abstract
Loading... -
+
P1.12-07 - Time to the End of Thoracic Radiotherapy Affects to Survival Outcomes Greater than Radiation Dose in Limited Stage Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Sung-Ja Ahn
- Abstract
Loading... -
+
P1.12-08 - The Effect of Cisplatin Versus Carboplatin on Cancer Outcomes for Small Cell Lung Cancer Patients in a Population-Based Cohort
16:45 - 18:00 | Author(s): Trevor Aquin
- Abstract
Loading... -
+
P1.12-09 - The Effect of Site of First Chemotherapy on Small Cell Lung Cancer Patient Outcomes
16:45 - 18:00 | Author(s): Rebekah Rittberg
- Abstract
Loading... -
+
P1.12-10 - Patterns of Curative Chemo-Radiotherapy Regimen and Impacts on the Outcome of Limited Stage SCLC in a Canadian Institution: 2010 – 2015 Diagnoses
16:45 - 18:00 | Presenter: Anifat A. Elegbede
- Abstract
Loading... -
+
P1.12-11 - 2010 – 2015 Extensive Stage SCLC Diagnoses in a Canadian Institution: Baseline Characteristics That Impact on the Overall Survival
16:45 - 18:00 | Presenter: Anifat A. Elegbede
- Abstract
Loading... -
+
P1.12-12 - A Systematic Review and Meta-Analysis of Early and Late Survival Following Anti-Cancer Therapies for Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Gavin S Jones
- Abstract
Loading... -
+
P1.12-13 - Impact of Chronic Obstructive Pulmonary Disease on the Survival of Patients with Extensive-Disease Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Eun Joo Kang
- Abstract
Loading... -
+
P1.12-14 - Survival of Patients with Small-Cell Lung Cancer Undergoing Surgical Resection
16:45 - 18:00 | Presenter: Shinji Kikuchi
- Abstract
Loading... -
+
P1.12-15 - Distinctive Clinical Characteristics of SCLC in Never-Smokers
16:45 - 18:00 | Presenter: Idrees Mian
- Abstract
Loading... -
+
P1.12-16 - Management of Elderly Small-Cell Lung Cancer Patients in a Romanian Tertiary Care Center
16:45 - 18:00 | Author(s): Teodora Alexa-Stratulat
- Abstract
Loading... -
+
P1.12-17 - Overall Survival and Recurrence After Surgical Resection of Pure and Mixed Large Cell Neuroendocrine Tumors.
16:45 - 18:00 | Presenter: Brooks Udelsman
- Abstract
Loading... -
+
P1.12-18 - Outcome in Small Cell Lung Cancer Patients with Cerebral Recurrence After Prior Prophylactic Cranial Irradiation
16:45 - 18:00 | Presenter: Lei Zhao
- Abstract
Loading... -
+
P1.12-19 - Clinico-Pathological Characteristics and Treatment Outcome in Small Cell Lung Cancer: A Single Institutional Experience
16:45 - 18:00 | Presenter: Sandip Ganguly
- Abstract
Loading... -
+
P1.12-20 - Overall Survival with Lurbinectedin Plus Doxorubicin in Relapsed SCLC. Results from an Expansion Cohort of a Phase Ib Trial.
16:45 - 18:00 | Presenter: Martin Forster
- Abstract
Loading... -
+
P1.12-21 - Developing a Real-World 3L Comparator to CheckMate 032: Overall Survival (OS) in Patients with Small Cell Lung Cancer (SCLC)
16:45 - 18:00 | Presenter: Lee S Schwartzberg
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 45
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.13-01 - Anti-EGF Antibodies Increase the Effect of ALK and MEK Inhibitors in ALK and KRAS NSCLC and CRC Cell Lines
16:45 - 18:00 | Presenter: Silvia Garcia - Roman
- Abstract
Loading... -
+
P1.13-02 - eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Leora Horn
- Abstract
Loading... -
+
P1.13-03 - Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Leora Horn
- Abstract
Loading... -
+
P1.13-04 - Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK Rearranged NSCLC
16:45 - 18:00 | Author(s): Ka-Won Noh
- Abstract
Loading... -
+
P1.13-05 - Integrin β3 Inhibition Enhances the Antitumor Activity of Alk Inhibitor in Alkrearranged NSCLC
16:45 - 18:00 | Presenter: Mi-Sook Lee
- Abstract
Loading... -
+
P1.13-06 - First-Line Lorlatinib Versus Crizotinib for Advanced Anaplastic Lymphoma Kinase-Positive (ALK+) Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Alice T. Shaw
- Abstract
Loading... -
+
P1.13-07 - Epithelial-Mesenchymal Transition Induced the Acquired Resistance to ALK Inhibitor Brigatinib in Lung Cancer Cells Harboring with ALK Fusions
16:45 - 18:00 | Presenter: Keiko Tanimura
- Abstract
Loading... -
+
P1.13-08 - Distribution, Differences in Clinical Characteristics and Resistance Mechanism of ALK Variants in Chinese Lung Cancer Patients.
16:45 - 18:00 | Author(s): Jun Zhao
- Abstract
Loading... -
+
P1.13-09 - Efficacy and Tolerance of Osimertinib in Real Word Setting: Results of the French Early Access Program (EXPLORE T790M GFPC Study).
16:45 - 18:00 | Presenter: Jean Bernard Auliac
- Abstract
Loading... -
+
P1.13-10 - Aurora Kinase A Drives the Evolution of Resistance to Third Generation EGFR Inhibitors in Lung Cancer
16:45 - 18:00 | Author(s): Khyati Shah
- Abstract
Loading... -
+
P1.13-11 - PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment
16:45 - 18:00 | Presenter: Katrina Hueniken
- Abstract
Loading... -
+
P1.13-12 - EGFR Therapy in ASCL1 Positive Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Farhad Kosari
- Abstract
Loading... -
+
P1.13-13 - Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells
16:45 - 18:00 | Presenter: Eisuke Kurihara
- Abstract
Loading... -
+
P1.13-14 - The Molecular Landscape of Lung Adenocarcinomas with Activating EGFR Gene Mutations Determined by Targeted-Sequencing
16:45 - 18:00 | Author(s): Marcin Nicoś
- Abstract
Loading... -
+
P1.13-15 - Detection of EGFR Mutations in cfDNA and Development of Resistance
16:45 - 18:00 | Presenter: Grainne Mary O'Kane
- Abstract
Loading... -
+
P1.13-16 - The Diagnostic Accuracy of Circulating Tumor DNA for the Detection of EGFR-T790M Mutation in NSCLC: A Systematic Review and Meta-Analysis
16:45 - 18:00 | Presenter: Francesco Passiglia
- Abstract
Loading... -
+
P1.13-17 - Multicentre Phase II Trial of First-Line Afatinib in Patients with Suspected/Confirmed EGFR Mutant NSCLC: ctDNA & Long-Term Efficacy
16:45 - 18:00 | Author(s): Sanjay Popat
- Abstract
Loading... -
+
P1.13-18 - Exploring the Resistance Mechanism of Osimertinib and Monitoring the Treatment Response Using Plasma ctDNA in Chinese NSCLC Patients
16:45 - 18:00 | Presenter: Yuankai Shi
- Abstract
Loading... -
+
P1.13-19 - Treatment Cessation for Improved Detection of EGFR-Mutated Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer (aNSCLC)
16:45 - 18:00 | Presenter: Samer Tabchi
- Abstract
Loading... -
+
P1.13-20 - MET Protein Expression and Activation During Targeted Therapy in EGFR Mutated Lung Adenocarcinoma
16:45 - 18:00 | Author(s): Riccardo Taulli
- Abstract
Loading... -
+
P1.13-21 - Clinical Efficacy and Safety of Apatinib Combined with EGFR - TKIs in Advanced Non-Small Cell Lung Cancer with EGFR - TKIs Resistance
16:45 - 18:00 | Author(s): Xia Song
- Abstract
Loading... -
+
P1.13-22 - Clinical Features and Outcomes of NSCLC Patients with Uncommon EGFR Mutations Treated with EGFR-TKIs
16:45 - 18:00 | Presenter: Roxana Alina Tudor
- Abstract
Loading... -
+
P1.13-23 - TP53 Mutations as Mechanisms of Primary and Acquired Resistance to Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated NSCLC
16:45 - 18:00 | Author(s): Matteo Canale
- Abstract
Loading... -
+
P1.13-24 - EGFR-KDD is Rare and Demonstrates Variable Anti-Tumor Response to Tyrosine Kinase Inhibitors in East Asian NSCLC Population
16:45 - 18:00 | Author(s): Jinguang Wang
- Abstract
Loading... -
+
P1.13-25 - Efficacy and Safety of Osimertinib in EGFR T790M-Positive Advanced NSCLC Patients with Brain Metastases (APOLLO Study)
16:45 - 18:00 | Presenter: Ligang Xing
- Abstract
Loading... -
+
P1.13-26 - First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant Nsclc Patients with Oligoprogressive Disease
16:45 - 18:00 | Presenter: Qinghua Xu
- Abstract
Loading... -
+
P1.13-27 - A Randomized Study of Concurrent vs Sequential Alternating EGFR-TKIs and Chemotherapy for Advanced NSCLC with EGFR Mutations
16:45 - 18:00 | Presenter: He Zhi Yong
- Abstract
Loading... -
+
P1.13-28 - The Functional MDM4 Genetic Polymorphsim as Prognostic Biomarker for Advanced Lung Adenocarcinoma Patients' Survival to EGFR-TKIs Therapy
16:45 - 18:00 | Presenter: Ming Yang
- Abstract
Loading... -
+
P1.13-29 - Overall Response Rate of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC
16:45 - 18:00 | Presenter: Joaquim Bosch Barrera
- Abstract
Loading... -
+
P1.13-30 - Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor and its Relationship to NSCLC Patient Outcomes in the REVEL Trial
16:45 - 18:00 | Author(s): Edward B Garon
- Abstract
Loading... -
+
P1.13-31 - Safety and Tumour Hypoxia Modifying Effect of Buparlisib with Radiotherapy in NSCLC: A Phase I Dose Escalation Study
16:45 - 18:00 | Presenter: Michael Skwarski
- Abstract
Loading... -
+
P1.13-32 - Comparison Between Immune-Mediated Pneumonitis and Pneumonia in Patients Treated with PD-1/PD-L1 Therapy
16:45 - 18:00 | Presenter: Mi Young Kim
- Abstract
Loading... -
+
P1.13-33 - Ex Vivo 2*2*2 Tumor Tissue Explant Culture for Precision Medicine in Immunotherapy and TKI progressors in Lung Cancer
16:45 - 18:00 | Author(s): Susmita Ghosh
- Abstract
Loading... -
+
P1.13-34 - Changes in Radiomic Features Between Baseline and Two Weeks Post-Nivolumab Treatment Are Predictive of Pathologic Complete Response
16:45 - 18:00 | Author(s): Mohammadhahi Khorrami
- Abstract
Loading... -
+
P1.13-35 - Hypoxia Mapping Using Oxygen-Enhanced MRI in Lung Cancer
16:45 - 18:00 | Presenter: Ahmed Salem
- Abstract
Loading... -
+
P1.13-36 - Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Lecia Sequist
- Abstract
Loading... -
+
P1.13-37 - Clinical Evaluation of Plasma-Based (cfDNA) Genomic Profiling in Over 1,000 Patients with Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Hai T Tran
- Abstract
Loading... -
+
P1.13-38 - Inter-Organ Heterogeneity on Mechanisms of Targeted Drug Resistance -Central Nervous System (CNS) vs Extra CNS-
16:45 - 18:00 | Presenter: Seiji Yano
- Abstract
Loading... -
+
P1.13-39 - Epidermal Growth Factor Receptor Mutation Among Non-Small Cell Lung Cancer Patients in Trinidad and Tobago: Frequency and Trends
16:45 - 18:00 | Presenter: Aaron Haralsingh
- Abstract
Loading... -
+
P1.13-40 - Rapid, Robust and Durable Responses to Larotrectinib in Patients with TRK Fusion Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Anna F. Farago
- Abstract
Loading... -
+
P1.13-41 - In Vitro Evaluation for Optimal MET-TKI Selection in Lung Cancers with MET Mutations Including Exon 14 Skipping
16:45 - 18:00 | Presenter: Toshio Fujino
- Abstract
Loading... -
+
P1.13-42 - Activity of Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance
16:45 - 18:00 | Presenter: Takamasa Koga
- Abstract
Loading... -
+
P1.13-43 - Molecular and Imaging Predictors of Response to Ado-Trastuzumab Emtansine in Patients with HER2 Mutant Lung Cancers: An Exploratory Phase 2 Trial
16:45 - 18:00 | Presenter: Bob T. Li
- Abstract
Loading... -
+
P1.13-44 - Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
16:45 - 18:00 | Presenter: Joel W. Neal
- Abstract
Loading... -
+
P1.13-45 - Coexistence of Activating BRAF and KRAS Mutations in Lung Cancer Patients
16:45 - 18:00 | Presenter: yingyi Wang
- Abstract
Loading...
-
+
P1.14 - Thymoma/Other Thoracic Malignancies (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 30
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.14-01 - Current Practices in the Management of Malignant Pericardial Effusions: A Survey Amongst Members of the European Society of Thoracic Surgeons.
16:45 - 18:00 | Presenter: Edward J Caruana
- Abstract
Loading... -
+
P1.14-02 - Predicting Stent Failure in Malignant Esophageal Obstruction
16:45 - 18:00 | Presenter: Tommi Kalle Markus Järvinen
- Abstract
Loading... -
+
P1.14-03 - Phase II Trial of Amrubicin and Cisplatin Chemotherapy for Invasive Thymoma: WJOG5509L
16:45 - 18:00 | Presenter: Keita Kudo
- Abstract
Loading... -
+
P1.14-04 - Stereotactic Body Radiation Therapy for Pleural Recurrences of Thymoma
16:45 - 18:00 | Author(s): Fabiano Emmanuelle
- Abstract
Loading... -
+
P1.14-05 - The Association of Pulmonary Function with Survival After Treatment in Patients with Esophageal Cancer
16:45 - 18:00 | Presenter: Hsien-Chi John Liao
- Abstract
Loading... -
+
P1.14-06 - Treatment Outcomes of Patients with Thymic Carcinoma: A Monocentric Experience of Sequential Regimens Modality
16:45 - 18:00 | Presenter: Margaret Ottaviano
- Abstract
Loading... -
+
P1.14-07 - Intraoperative Detection of Circulating Tumor Cells in Pulmonary Venous Blood During Metastasectomy for Colorectal Lung Metastases
16:45 - 18:00 | Presenter: Severin Schmid
- Abstract
Loading... -
+
P1.14-08 - The Usefulness of the Hemiclamshell Thoracotomy in Thoracic Surgery
16:45 - 18:00 | Presenter: Masanori Tsuchida
- Abstract
Loading... -
+
P1.14-09 - Outcome After Lung Resection for Primary Lung Carcinomas/Metastasis in Patients with Performed Total Laryngectomy for Laryngeal Carcinoma
16:45 - 18:00 | Author(s): Gamze Çetinkaya
- Abstract
Loading... -
+
P1.14-10 - Surgical Treatment of a Rare Case of Clear Cell Carcinomatous Transformation of a Diaphragmatic Endometriosis Focus
16:45 - 18:00 | Presenter: Angela De Palma
- Abstract
Loading... -
+
P1.14-11 - The Expression Pattern of Programmed Death-Ligand 1 According to the Pathological Type of Malignant Thymic Epithelial Tumors
16:45 - 18:00 | Presenter: Shunta Ishihara
- Abstract
Loading... -
+
P1.14-12 - GTF2I Mutation in Thymomas: Indian and German Study
16:45 - 18:00 | Presenter: Deepali Jain
- Abstract
Loading... -
+
P1.14-13 - PD-L1 Immuno-Expression Assay in Thymomas: A Study from India
16:45 - 18:00 | Presenter: Deepali Jain
- Abstract
Loading... -
+
P1.14-14 - Histotyping of Indian Thymomas: A Comprehensive Clinicopathologic Study
16:45 - 18:00 | Presenter: Deepali Jain
- Abstract
Loading... -
+
P1.14-15 - Prevalence of Mediastinal Tumors Using Low-Dose Spiral Computed Tomography in Healthy Population
16:45 - 18:00 | Presenter: Ikuma Kasuga
- Abstract
Loading... -
+
P1.14-16 - DNA Methylation of GNG4、GHSR、HOXD9 and SALL3 Genes Predict Malignant Behavior of Thymic Epithelial Tumors
16:45 - 18:00 | Author(s): Kazuya Kondo
- Abstract
Loading... -
+
P1.14-17 - Identification of Molecular Subtypes of Thymic Epithelial Tumors and Novel Treatments Using a Computational Biological Model
16:45 - 18:00 | Presenter: Sukhmani Kaur Padda
- Abstract
Loading... -
+
P1.14-18 - The Promising Role of Sunitinib Rechallenge in Heavily Pre-Treated Thymic Carcinoma: A Case Report
16:45 - 18:00 | Presenter: Giovannella Palmieri
- Abstract
Loading... -
+
P1.14-19 - Hemagglutinating Virus of Japan Envelope (HVJ-E: Inactivated Viral Nanoparticles) Against Chemotherapy-Resistant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Kazuma Sakura
- Abstract
Loading... -
+
P1.14-20 - The Expression of DNA Methylation of GAD1 Gene is an Indicator of Malignant Behavior in Thymic Epithelial Tumor.
16:45 - 18:00 | Presenter: Kazuya Kondo
- Abstract
Loading... -
+
P1.14-21 - Circulating Biomarkers in Thymic Epithelial Tumors
16:45 - 18:00 | Author(s): Daniel Valdivia
- Abstract
Loading... -
+
P1.14-22 - The Prognostic Role of the Suppressor of Cytokine Signaling-5 (SOCS5) in Esophageal Squamous Cell Carcinoma
16:45 - 18:00 | Presenter: Pei-Wen Yang
- Abstract
Loading... -
+
P1.14-23 - Thymoma: An Epidemiological and Clinico-Pathological Profile in Nepalese Population.
16:45 - 18:00 | Presenter: Sandhya Chapagain Acharya
- Abstract
Loading... -
+
P1.14-24 - External Radiotherapy Concurrent with Cisplatin Plus 5- Flurouracil in Locally Advanced Carcinoma of Esophagus
16:45 - 18:00 | Presenter: Rashmey Pun
- Abstract
Loading... -
+
P1.14-25 - Pulmonary Metastasis from Oral Cancer – Who Survive Without Recurrence After Pulmonary Metasectomy?
16:45 - 18:00 | Presenter: Chihiro Takasaki
- Abstract
Loading... -
+
P1.14-26 - Long Term Outcome and Clinicopathological Features of Thymic Carcinoma - A Retrospective Study of 25 Cases at a Single Institution
16:45 - 18:00 | Presenter: Hiroto Tanaka
- Abstract
Loading... -
+
P1.14-27 - Differentiation Between Each Thymic Epithelial Tumor According to WHO Classification Scheme by Using MDCT Findings
16:45 - 18:00 | Presenter: Yutthaphan Wannasopha
- Abstract
Loading... -
+
P1.14-28 - Frequent Genetic Alterations and Their Clinical Significance in Patients with Thymic Epithelial Tumors
16:45 - 18:00 | Presenter: Song Xu
- Abstract
Loading... -
+
P1.14-29 - Surgical Treatment for Metastatic Lung Tumors from Various Sarcomas
16:45 - 18:00 | Presenter: Hiromasa Yamamoto
- Abstract
Loading... -
+
P1.14-30 - Prognostic Factors for Sarcoma Patients with Lung Metastasis Who Underwent Extended Pulmonary Resection
16:45 - 18:00 | Presenter: Haruchika Yamamoto
- Abstract
Loading...
-
+
P1.15 - Treatment in the Real World - Support, Survivorship, Systems Research (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 37
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.15-01 - Radiotherapy (RT) and Nivolumab in Non-Small-Cell Lung Cancer (NSCLC): A Multicenter Real-Life Experience
16:45 - 18:00 | Author(s): Maria Bassanelli
- Abstract
Loading... -
+
P1.15-02 - Migration Differences in Small Cell vs Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Shruti Bhandari
- Abstract
Loading... -
+
P1.15-03 - Clinical Characteristics of Long-Term Survivors With Nivolumab in Pretreated Advanced NSCLC
from Real-World Data (RWD)16:45 - 18:00 | Author(s): Miguel Garcia
- Abstract
Loading... -
+
P1.15-04 - Practice Patterns Regarding Multidisciplinary Cancer Management for NSCLC and implemetantion: Results of National Survey in México
16:45 - 18:00 | Presenter: Saul Campos-Gomez
- Abstract
Loading... -
+
P1.15-05 - The Frequency and Spectrum of EGFR Exon 20 Insertions in NSCLC: A Global Literature Review
16:45 - 18:00 | Presenter: Victoria Crossland
- Abstract
Loading... -
+
P1.15-06 - Integrative Quality Improvement for Management of Lung Cancer in Uganda
16:45 - 18:00 | Presenter: Semujju David
- Abstract
Loading... -
+
P1.15-07 - Geriatric Oncology - Lung Cancer in Elderly Patients and Palliative Treatment: Prospective Analysis of A. C. Camargo Cancer Center
16:45 - 18:00 | Presenter: Mauro DS Donadio
- Abstract
Loading... -
+
P1.15-08 - Implementation and Feasibility of the Assessment of EGFR Mutation in NSCLC Using Liquid Biopsy at an Argentinean University Hospital
16:45 - 18:00 | Presenter: Carolina Gabay
- Abstract
Loading... -
+
P1.15-09 - Trends in Lung Cancer Survival in Lithuania
16:45 - 18:00 | Presenter: Vaida Gedvilaite
- Abstract
Loading... -
+
P1.15-10 - Comparison of Selected Colombian National Administrative Cancer Registry (NACR) Data in Lung Cancer with the U.S.
16:45 - 18:00 | Presenter: Robert Hsu
- Abstract
Loading... -
+
P1.15-11 - Lung Cancer as One of Multiple Cancers: A Population-Based Study in Estonia 1995-2015
16:45 - 18:00 | Presenter: Jana Jaal
- Abstract
Loading... -
+
P1.15-12 - Real World Applications of Next-Generation Sequencing of Non-Small Cell Lung Cancer in the Veteran Population
16:45 - 18:00 | Presenter: Jeremy Kratz
- Abstract
Loading... -
+
P1.15-13 - Wait Times for Diagnosis and Treatment of Lung Cancer Across the Province of Quebec, Canada
16:45 - 18:00 | Presenter: Catherine Labbe
- Abstract
Loading... -
+
P1.15-14 - Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study
16:45 - 18:00 | Presenter: Hyun Woo Lee
- Abstract
Loading... -
+
P1.15-15 - Real-World Experience with Afatinib after Failure of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
16:45 - 18:00 | Presenter: Chong-Kin Liam
- Abstract
Loading... -
+
P1.15-16 - ALKConnect: An Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Patient Insights Network
16:45 - 18:00 | Presenter: Huamao M Lin
- Abstract
Loading... -
+
P1.15-17 - Risk Factors of Local Recurrence in EGFR-Mutant Stage III-pN2 Adenocarcinoma After Complete Resection: A Multi-Center Real-World Cohort Study
16:45 - 18:00 | Author(s): Qi-Wen Li
- Abstract
Loading... -
+
P1.15-18 - The Impact of Patient Age on Clinical Outcomes in NSCLC: A National Study
16:45 - 18:00 | Presenter: Yanyan Lou
- Abstract
Loading... -
+
P1.15-19 - Treatment of Choice for First-Line Therapy of EGFR-Mutated Stage IIIB Lung Adenocarcinoma Based on the Real World Data
16:45 - 18:00 | Presenter: Shun Lu
- Abstract
Loading... -
+
P1.15-20 - Diagnosis and Treatment Delay Among Patients with Lung Cancer in Mexican Population
16:45 - 18:00 | Presenter: Omar Macedo-Pérez
- Abstract
Loading... -
+
P1.15-21 - Creating an Optimal Care Coordination Model to Improve Multidisciplinary Care for Lung Cancer Patients on Medicaid
16:45 - 18:00 | Author(s): Amy M Marbaugh
- Abstract
Loading... -
+
P1.15-22 - Patterns of Palliative and Psychosocial Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients
16:45 - 18:00 | Presenter: Tahir Mehmood
- Abstract
Loading... -
+
P1.15-23 - Factors Affecting Treatment in Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Phuong T Ngo
- Abstract
Loading... -
+
P1.15-24 - Small Cell Lung Cancer: Clinical Characteristics and Survival of a Spanish Cohort of 221 Patients
16:45 - 18:00 | Author(s): Beatriz Núñez
- Abstract
Loading... -
+
P1.15-25 - Has Lung Cancer Radiotherapy Utilisation Changed over Time in New South Wales, Australia?
16:45 - 18:00 | Author(s): Andrew Oar
- Abstract
Loading... -
+
P1.15-26 - A Review of Colombian National Administrative Cancer Registry (NACR) Data to Evaluate Healthcare Delivery and Biologics Use
16:45 - 18:00 | Author(s): Robert Hsu
- Abstract
Loading... -
+
P1.15-27 - Patient Characteristics, Treatment Patterns and Survival for Unresectable Stage III NSCLC in Ontario, Canada.
16:45 - 18:00 | Presenter: Soo Jin Seung
- Abstract
Loading... -
+
P1.15-28 - Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada.
16:45 - 18:00 | Presenter: Soo Jin Seung
- Abstract
Loading... -
+
P1.15-29 - Impact of Radiation Therapy Quality Assurance on Progression-Free and Overall Survival in Randomized Trials of Lung Cancer
16:45 - 18:00 | Presenter: Yu Yang Soon
- Abstract
Loading... -
+
P1.15-30 - Survival of Patients with Advanced NSCLC Treated with First-Generation EGFR-TKIs at a Cancer Hospital in Thailand, 2011-2016
16:45 - 18:00 | Presenter: Sitthi Sukauichai
- Abstract
Loading... -
+
P1.15-31 - Survival and Patterns of Care Comparing Black and White Patients With All Stages of NSCLC: An NCDB Analysis
16:45 - 18:00 | Presenter: Melissa Ana Liriano Vyfhuis
- Abstract
Loading... -
+
P1.15-32 - Real World EGFR Mutation Profile from 1699 Non-Small Cell Lung Cancer Patients in Eastern China
16:45 - 18:00 | Presenter: Wei Wang
- Abstract
Loading... -
+
P1.15-33 - Real-World Data on Prognostic Factors for Overall Survival in NSCLC Patients Treated with Bevacizumab Combination Therapy
16:45 - 18:00 | Presenter: Shang-Gin Wu
- Abstract
Loading... -
+
P1.15-34 - Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare
16:45 - 18:00 | Presenter: Dimas Yusuf
- Abstract
Loading... -
+
P1.15-35 - Real World Outcome of Different Administrations Endostar Combined With Chemotherapy in Driver Gene Mutation Negative Advanced NSCLC
16:45 - 18:00 | Presenter: Yongchang Zhang
- Abstract
Loading... -
+
P1.15-36 - A Better Real World Practice for Pemetrexed in First-Line Treatment of Advanced Mon-Squamous Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Yongchang Zhang
- Abstract
Loading... -
+
P1.15-36a - Assessment of Depression Among Advanced Stage Lung Cancer Patients in Developing Country
16:45 - 18:00 | Presenter: Guru Sharan Sah
- Abstract
Loading...
-
+
P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 64
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.16-01 - Prognostic Variables Associated with Improved Outcomes in Stage III NSCLC Patients Treated with Consolidation Pembrolizumab
16:45 - 18:00 | Presenter: Bilal Anouti
- Abstract
Loading... -
+
P1.16-02 - Support and Information Needs for Patients with NSCLC Receiving Concurrent Chemo-Radiotherapy: Findings from the INSIGHT Study.
16:45 - 18:00 | Presenter: Jackie Fenemore
- Abstract
Loading... -
+
P1.16-03 - Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Mustafa Karaca
- Abstract
Loading... -
+
P1.16-04 - Outcomes of Patients < 70 or ≥70 Years of Age in PACIFIC
16:45 - 18:00 | Presenter: Mark A Socinski
- Abstract
Loading... -
+
P1.16-05 - Effect of Induction Chemotherapy in the PACIFIC Study
16:45 - 18:00 | Presenter: David R. Spigel
- Abstract
Loading... -
+
P1.16-06 - Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%
16:45 - 18:00 | Presenter: Alexander Spira
- Abstract
Loading... -
+
P1.16-07 - Cost-Effectiveness of Pembrolizumab as 1st Line Treatment for Metastatic NSCLC Patients with High PD-L1 Expression in Singapore
16:45 - 18:00 | Presenter: Wan Ling Tan
- Abstract
Loading... -
+
P1.16-08 - Weekly Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy for IIIA-N2 Lung Squamous Cell Carcinoma: A Prospective Phase II Study
16:45 - 18:00 | Author(s): Yu Zhang
- Abstract
Loading... -
+
P1.16-09 - Surgical Result of Pathologic Stage III a Non Small Cell Lung Cancer: Have We Improved?
16:45 - 18:00 | Presenter: Ching-Yang Wu
- Abstract
Loading... -
+
P1.16-10 - Marginal Features Analyses of Lung Adenocarcinoma for Survival Prediction
16:45 - 18:00 | Presenter: Geewon Lee
- Abstract
Loading... -
+
P1.16-11 - Monitoring of Early Stage Lung Cancer Using Liquid Biopsies.
16:45 - 18:00 | Presenter: Alexander Dobrovic
- Abstract
Loading... -
+
P1.16-12 - Identification of a Biomarker Panel in Resected NSCLC That Predicts Patient Outcomes and Benefit from Adjuvant Chemotherapy
16:45 - 18:00 | Presenter: Stacy Grieve
- Abstract
Loading... -
+
P1.16-13 - Photo Dynamic Therapy (PDT) in Our Hospital
16:45 - 18:00 | Presenter: Fumihiko Hoshi
- Abstract
Loading... -
+
P1.16-14 - Impact of Smoking on Treatment Outcome in Early Squamous Cell Lung Cancer (T1N0)
16:45 - 18:00 | Presenter: Junghee Lee
- Abstract
Loading... -
+
P1.16-15 - Evaluation of Emphysema Severity by 3D-CT for Predicting Postoperative Respiratory Complications and Prognosis of Lung Cancer
16:45 - 18:00 | Presenter: Yojiro Makino
- Abstract
Loading... -
+
P1.16-16 - Automatic Intratumor Segmentation in CT of NSCLC: An Alternative to PET Metabolic Subregions
16:45 - 18:00 | Presenter: Qintao Qiu
- Abstract
Loading... -
+
P1.16-17 - The Role of Quantitative Metabolic Metrics on FDG-PET/CT in Predicting Pathological Invasive Factors in cN0 Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Takehiko Tanaka
- Abstract
Loading... -
+
P1.16-18 - Role of ERCC1/2 Single Nucleotide Polymorphism (SNP) on Treatment Response in Patients with Lung Cancer Undergoing Radiation Therapy
16:45 - 18:00 | Author(s): Yaoyao Zhu
- Abstract
Loading... -
+
P1.16-19 - Neither Maximum Tumor Size nor Solid Component Size Was the Best Prognosticator for Subsolid Nodule
16:45 - 18:00 | Presenter: Erjia Zhu
- Abstract
Loading... -
+
P1.16-20 - A Systematic Review and Meta-Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients with Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Christopher Cao
- Abstract
Loading... -
+
P1.16-21 - Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients with Locally Advanced NSCLC
16:45 - 18:00 | Presenter: Yuko Kawano
- Abstract
Loading... -
+
P1.16-22 - Meta-Analysis of Stereotactic Ablative Radiotherapy Versus Surgery for Early Stage Lung Cancer.
16:45 - 18:00 | Presenter: Janusz Kowalewski
- Abstract
Loading... -
+
P1.16-23 - Long-Term Survival Analysis of Surgery in Potential Stereotactic Ablative Radiotherapy Candidates of Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Shaolei Li
- Abstract
Loading... -
+
P1.16-24 - Impact of Tumor Location & Dosimetric Predictors for Chest Wall Toxicity in Single Fraction SBRT for Stage I Non-Small Cell Lung Cancer
16:45 - 18:00 | Author(s): Bindu Manyam
- Abstract
Loading... -
+
P1.16-25 - A Propensity Score Model for Appropriate Treatment Selection (Sublobar Resection vs. SBRT) In Patients With cStage I NSCLC
16:45 - 18:00 | Presenter: Yukinori Matsuo
- Abstract
Loading... -
+
P1.16-26 - Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) with 50 Gray in 5 Fractions (50Gy/5f)
16:45 - 18:00 | Presenter: Robert Rulach
- Abstract
Loading... -
+
P1.16-27 - Using Rates of Clinical Brachial Plexopathy after Lung SBRT to Better Characterize the Tolerance of the Brachial Plexus
16:45 - 18:00 | Presenter: Kyle Verdecchia
- Abstract
Loading... -
+
P1.16-28 - The Impact of Spironolactone on the Lung Injury Induced by Concomitant Trastuzumab and Thoracic Radiotherapy
16:45 - 18:00 | Presenter: Guler Yavas
- Abstract
Loading... -
+
P1.16-29 - Accelerated Hypofractionated Radiotherapy for Central Lung Tumors Unsuitable for Stereotactic Body Radiotherapy Or Concurrent CRT
16:45 - 18:00 | Presenter: K. Liang Zeng
- Abstract
Loading... -
+
P1.16-30 - Quality of Lymphadenectomy During Lobectomy for Non-small Cell Lung Cancer: VATS Versus Thoracotomy
16:45 - 18:00 | Presenter: Raquel Sâmia Gonzaga Alves
- Abstract
Loading... -
+
P1.16-31 - Surgically Resected Acinar Adenocarcinoma of the Lung: Analysis of Different Prognostic Groups.
16:45 - 18:00 | Presenter: Pietro Bertoglio
- Abstract
Loading... -
+
P1.16-32 - Lung Cancer Completeness of Resection in Uniportal Versus Multiportal Video-Assisted Thoracoscopic Surgery Lobectomy
16:45 - 18:00 | Presenter: Etienne Bourdages-Pageau
- Abstract
Loading... -
+
P1.16-33 - Occult Lymph Node Metastases in Early Stage NSCLC Patients: Where Do We Stand Now? A Proposal for a Preoperative Risk Model
16:45 - 18:00 | Presenter: Giuseppe Cipollone
- Abstract
Loading... -
+
P1.16-34 - The Impact of Pathology, Staging and Operative Resection on Survival and CT Evidence of Recurrence of Early NSCLC
16:45 - 18:00 | Presenter: Richard John Finley
- Abstract
Loading... -
+
P1.16-35 - Sleeve Lobectomy Versus Pneumonectomy for Non-Small Cell Lung Cancer, a Cumulative Updated Meta-Analysis
16:45 - 18:00 | Presenter: Zhihua Guo
- Abstract
Loading... -
+
P1.16-36 - Real-Time Ct Guided Video Assisted Thoracoscopic Partial Resection of Peripheral Small-Sized Lung Tumors.
16:45 - 18:00 | Presenter: Taisuke Kaiho
- Abstract
Loading... -
+
P1.16-37 - Clinicopathological Characteristics and Prognostic Factors of Operable Non-Small Cell Lung Cancer Patients with the Diabetes Mellitus
16:45 - 18:00 | Presenter: Kaoru Kaseda
- Abstract
Loading... -
+
P1.16-38 - Meta-Analysis of Unplanned Readmissions Following Thoracoscopic Versus Open Lung Cancer Resection
16:45 - 18:00 | Presenter: Janusz Kowalewski
- Abstract
Loading... -
+
P1.16-39 - A Nomogram for Predicting Survival Of TNM8 Stage I Non-Small Cell Lung Cancer Patients to Tailor Potential Chemotherapy Candidates
16:45 - 18:00 | Presenter: Wenhua Liang
- Abstract
Loading... -
+
P1.16-40 - Evaluating the Tumor Heterogeneity in Lung Cancer by Constructing Tumor Heterogeneity Index (THI) from Magnetic Resonance Imaging
16:45 - 18:00 | Author(s): Qi-Wen Li
- Abstract
Loading... -
+
P1.16-41 - The Role of Surgery in Pulmonary Large Cell Neuroendocrine Carcinoma: A Propensity-Score Matching Analysis of SEER Database
16:45 - 18:00 | Presenter: Zhichao Liu
- Abstract
Loading... -
+
P1.16-42 - Indocyanine Green Intersegmental Visualization During Fluorescence Imaging of Thoracoscopic Anatomic Segmentectomy: A Novel Approach
16:45 - 18:00 | Presenter: Takuya Matsui
- Abstract
Loading... -
+
P1.16-43 - Analyses of Long-Term Outcomes and Prognostic Factors in Surgically Resected ALK-Rearranged Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yosuke Matsuura
- Abstract
Loading... -
+
P1.16-44 - Minute Ventilation-To-Carbon Dioxide Slope is Associated with Early and Long Term Survivals Following Anatomical Pulmonary Resection
16:45 - 18:00 | Presenter: Takuro Miyazaki
- Abstract
Loading... -
+
P1.16-45 - Thoracoscopic Stapler-Based Complex Segmentectomy Assisted by Virtual Assisted Lung Mapping
16:45 - 18:00 | Presenter: Jun-ichi Nitadori
- Abstract
Loading... -
+
P1.16-46 - A Population-Based Validation Study of the Proposed ‘R-Factor’ Classification in a Lung Cancer-Endemic Region of the US.
16:45 - 18:00 | Author(s): Matthew P Smeltzer
- Abstract
Loading... -
+
P1.16-47 - Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
16:45 - 18:00 | Presenter: Geoffrey R. Oxnard
- Abstract
Loading... -
+
P1.16-48 - The Impact of Segmentectomy Versus Lobectomy on Pulmonary Function of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
16:45 - 18:00 | Presenter: Guanping Qiu
- Abstract
Loading... -
+
P1.16-49 - Treatment of NSCLC Patients with Clinical N1 Disease: Is There an Advantage to Neoadjuvant Therapy?
16:45 - 18:00 | Author(s): Mohamed Rahouma
- Abstract
Loading... -
+
P1.16-50 - The Role of Adjuvant Therapy for Patients with Early Stage Large Cell Neuroendocrine Lung Cancer: A National Analysis
16:45 - 18:00 | Presenter: Vignesh Raman
- Abstract
Loading... -
+
P1.16-51 - Preop Nutrition-Enhanced Recovery After Surgery Protocol for Thoracic Cancer Resections Decreases Hospital Days and Charges
16:45 - 18:00 | Presenter: Lary A. Robinson
- Abstract
Loading... -
+
P1.16-52 - Long-Term Impact of Postoperative Complications Following Lung Resection Among Patients with Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Shuichi Shinohara
- Abstract
Loading... -
+
P1.16-53 - County-Level Variations and Contributing Factors in Receipt of Surgery for Early-Stage Non-Small Cell Lung Cancer in the US
16:45 - 18:00 | Author(s): Helmneh M Sineshaw
- Abstract
Loading... -
+
P1.16-54 - The Significance of Multiple Lung Cancer Occurrence in Surgically-Treated Clincal Stage I Lung Cancer
16:45 - 18:00 | Presenter: Hiroshi Sugimura
- Abstract
Loading... -
+
P1.16-55 - Surgical Treatment for Lung Cancer. Subaortic (Para-Aortic) Lymph Nodes Involvement - N1 or N2 Disease?
16:45 - 18:00 | Presenter: Magdalena Szczęsna
- Abstract
Loading... -
+
P1.16-56 - Prognostic Ability of New T1 Descriptors in the TNM Classification of Surgically Treated Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Tomoyoshi Takenaka
- Abstract
Loading... -
+
P1.16-57 - Outcomes of Pulmonary Resection in Elderly Non-Small Cell Lung Cancer Patient
16:45 - 18:00 | Presenter: Apichat Tantraworasin
- Abstract
Loading... -
+
P1.16-58 - Hospital Lung Surgery Volume and Patient Outcomes in Victoria
16:45 - 18:00 | Presenter: Alesha A Thai
- Abstract
Loading... -
+
P1.16-59 - A Phase II Study of Adjuvant Chemotherapy with Tegafur-Uracil for Vessel Invasion Positive Stage IA Non-Small Cell Lung Cancer (LOGIK0602)
16:45 - 18:00 | Presenter: Tomoshi Tsuchiya
- Abstract
Loading... -
+
P1.16-60 - A High Risk of Recurrence After the Resection of Lower Lobe Adenocarcinoma
16:45 - 18:00 | Presenter: Kazuhiro Ueda
- Abstract
Loading... -
+
P1.16-61 - Intermittent Chest Tube Clamping Shortens Chest Tube Duration After Lung Cancer Surgery: An Interim Analysis of Randomized Clinical Trial
16:45 - 18:00 | Presenter: Shi Yan
- Abstract
Loading... -
+
P1.16-62 - A Nomogram to Predict Disease-Free Survival After Curative Resection of Non-Small Cell Lung Cancer
16:45 - 18:00 | Author(s): Xiaoyu Zhai
- Abstract
Loading... -
+
P1.16-63 - The Value of Adjuvant Chemotherapy in Patients with Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Shuhui Cao
- Abstract
Loading... -
+
P1.16-64 - The Histological Predominant Pattern Could Predict Site of Recurrence and Metastasis in Surgically Treated Stage I Adenocarcinoma of the Lung
16:45 - 18:00 | Presenter: Francesco Guerrera
- Abstract
Loading...
-
+
P1.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 20
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.17-01 - Robustness of an Image-Based Data Mining Approach in Lung Cancer Patients
16:45 - 18:00 | Author(s): Eliana Vasquez Osorio
- Abstract
Loading... -
+
P1.17-02 - Low Prognostic Nutritional Index Predicts Poor Survival in Stage IIIB Non-Small Cell Lung Cancer Patients Treated with Chemoradiotherapy
16:45 - 18:00 | Presenter: Ali Ayberk Besen
- Abstract
Loading... -
+
P1.17-03 - Potential Associated SNPs by GWAS with Radiation Pneumonitis (RP) in Patients with Lung Cancer Treated with Radiotherapy
16:45 - 18:00 | Presenter: Lehui Du
- Abstract
Loading... -
+
P1.17-04 - Curative Intent Treatment for Stage III NSCLC in England
16:45 - 18:00 | Presenter: Susan V Harden
- Abstract
Loading... -
+
P1.17-05 - Accelerated Radiotherapy for Non-Small Cell Lung Cancer: A 12 Year Retrospective Review of Two Dose Fractionation Schedules
16:45 - 18:00 | Author(s): Stephen D Robinson
- Abstract
Loading... -
+
P1.17-06 - Salvage Surgery After Chemotherapy and/or Radiotherapy Including SBRT and Proton: Consecutive Analysis of 46 Patients
16:45 - 18:00 | Presenter: Aki Katarina Kobayashi
- Abstract
Loading... -
+
P1.17-07 - The Prognostic Value of Volumetric Changes of the GTV Measured on CBCT During Radiotherapy for CCRT in NSCLC Patients
16:45 - 18:00 | Author(s): Margriet Kwint
- Abstract
Loading... -
+
P1.17-08 - Genetic Predictors of Response to Chemoradiation in Stage III Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Leo Luo
- Abstract
Loading... -
+
P1.17-09 - V30 May Better Predict Radiation Pneumonitis After Intensity-Modulated Radiation Therapy for Lung Cancer
16:45 - 18:00 | Presenter: Yinnan Meng
- Abstract
Loading... -
+
P1.17-10 - Consolidation Chemotherapy in Stage III Non-Small Cell Lung Cancer: Still a Critical Piece of the Puzzle
16:45 - 18:00 | Presenter: Pranshu Mohindra
- Abstract
Loading... -
+
P1.17-11 - Pattern and Survival Impact of Neoadjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) in a Prospective Lung Resection Cohort
16:45 - 18:00 | Presenter: Meredith A Ray
- Abstract
Loading... -
+
P1.17-12 - Colleague Peer Review of Radical Lung Radiotherapy Treatment Plans: The Impact on Interval from Decision to Treat to Treatment Delivery
16:45 - 18:00 | Author(s): Claire Mary Rooney
- Abstract
Loading... -
+
P1.17-13 - The Role of Post-Operative Radiation Therapy in Patients with Locally Advanced NSCLC after Nodal Down-Staging with Systemic Chemotherapy
16:45 - 18:00 | Presenter: Annemarie Shepherd
- Abstract
Loading... -
+
P1.17-14 - Outcomes of Hypofractionated Radiation Therapy (HFRT) with Concurrent Chemotherapy in Patients with Stage III Non Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Annemarie Shepherd
- Abstract
Loading... -
+
P1.17-15 - Perioperative Prognostic Nutrition Index for Induction Chemoradiotherapy Followed by Surgery in Locally Advanced Non-Small Lung Cancers
16:45 - 18:00 | Presenter: Junichi Soh
- Abstract
Loading... -
+
P1.17-16 - Correlation of Tumor Volume Reduction During Neoadjuvant Chemoradiotherapy with Pathological Complete Response of Lung Cancer
16:45 - 18:00 | Presenter: Shigeo Takahashi
- Abstract
Loading... -
+
P1.17-17 - The Impact of Induction Chemoradiotherapy Followed by Surgery for N1 Involved Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Yuta Takahashi
- Abstract
Loading... -
+
P1.17-18 - Treatment for Patients with T4 Superior Sulcus Non-Small Cell Lung Cancer: A Propensity-Matched Analysis of SEER Database
16:45 - 18:00 | Author(s): Junmiao Wen
- Abstract
Loading... -
+
P1.17-19 - Correlation of Dosimetric and Clinical Factors with Radiation Pneumonitis in Lung Cancer Patients Received Involved-Field IMRT
16:45 - 18:00 | Presenter: Lehui Du
- Abstract
Loading... -
+
P1.17-20 - Excluding PTV From Lung Volume May Better Predict Radiation Pneumonitis For IMRT Treated Lung Cancer Patients
16:45 - 18:00 | Presenter: Yinnan Meng
- Abstract
Loading...
-
+
MTE11 - Biology of Small Cell Lung Cancer (Ticketed Session)
- Type: Meet the Expert Session
- Track: Biology
- Presentations: 2
- Coordinates: 9/25/2018, 07:00 - 08:00, Room 203 BD
-
+
MTE11.01 - Novel Therapeutic Targets in SCLC
07:00 - 07:30 | Presenter: Julien Sage
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE11.02 - Biological Subsets of SCLC
07:30 - 08:00 | Presenter: Charles M. Rudin
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE12 - IO in the Real World - High Risk Populations And Patient Support (Ticketed Session)
- Type: Meet the Expert Session
- Track: Immunooncology
- Presentations: 2
- Coordinates: 9/25/2018, 07:00 - 08:00, Room 206 AC
-
+
MTE12.01 - Is IO an Option for Patients with Contraindications (Auto-immune Disease, Pulmonary Fibrosis, HIV, Hepatitis, Transplant etc)
07:00 - 07:40 | Presenter: Andrew G Robinson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE12.02 - How can we Minimize Toxicity for our High Risk Patients?
07:40 - 08:00 | Presenter: Massey Nematollahi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE13 - Clonal Evolution and Targeted Therapy (Ticketed Session)
- Type: Meet the Expert Session
- Track: Targeted Therapy
- Presentations: 2
- Coordinates: 9/25/2018, 07:00 - 08:00, Room 201 BD
-
+
MTE13.01 - Clonal Evolution and Targeted Therapy
07:00 - 07:30 | Presenter: Ramaswamy Govindan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE13.02 - Clonal Evolution and Targeted Therapy
07:30 - 08:00 | Presenter: Janessa Laskin
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.